Cargando…
Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine
BACKGROUND: Despite advances in molecular medicine over recent decades, there has been little advancement in the treatment of osteosarcoma. We performed comprehensive molecular profiling in two cases of metastatic and chemotherapy-refractory osteosarcoma to guide molecularly targeted therapy. PATIEN...
Autores principales: | Subbiah, Vivek, Wagner, Michael J., McGuire, Mary F., Sarwari, Nawid M., Devarajan, Eswaran, Lewis, Valerae O., Westin, Shanon, Kato, Shumei, Brown, Robert E., Anderson, Pete |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747358/ https://www.ncbi.nlm.nih.gov/pubmed/26510912 |
Ejemplares similares
-
Theranostic profiling for actionable aberrations in advanced high risk osteosarcoma with aggressive biology reveals high molecular diversity: the human fingerprint hypothesis
por: Egas-Bejar, Daniela, et al.
Publicado: (2014) -
Clinical next-generation sequencing reveals aggressive cancer biology in adolescent and young adult patients
por: Subbiah, Vivek, et al.
Publicado: (2015) -
Chronic Epstein Barr virus infection leading to classical Hodgkin lymphoma
por: Sarwari, Nawid M., et al.
Publicado: (2016) -
223-Radium for metastatic osteosarcoma: combination therapy with other agents and external beam radiotherapy
por: Anderson, Pete M, et al.
Publicado: (2020) -
Successful Use of Adjunctive Red Blood Cell Exchange Therapy for Treatment of an Acute Hemolytic Reaction After ABO-Incompatible Red Blood Cell Transfusion
por: Moussly, Sammy, et al.
Publicado: (2019)